0001127602-23-018786.txt : 20230615
0001127602-23-018786.hdr.sgml : 20230615
20230615163906
ACCESSION NUMBER: 0001127602-23-018786
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230613
FILED AS OF DATE: 20230615
DATE AS OF CHANGE: 20230615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ASELAGE STEVE
CENTRAL INDEX KEY: 0001221599
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 231017952
MAIL ADDRESS:
STREET 1: 6300 DUMBARTON CIRCLE
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-06-13
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001221599
ASELAGE STEVE
4505 EMPEROR BOULEVARD
SUITE 200
DURHAM
NC
27703
1
0
Common Stock
2023-06-13
4
A
0
16745
0
A
63339
D
Automatic Stock Option Grant
8.18
2023-06-13
4
A
0
39072
0
A
2024-06-13
2033-06-13
Common Stock
39072
39072
D
Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.
/s/ Alane P. Barnes, by power of attorney
2023-06-15